CN101076535A - 二氟核苷及其制备方法 - Google Patents

二氟核苷及其制备方法 Download PDF

Info

Publication number
CN101076535A
CN101076535A CNA2005800423787A CN200580042378A CN101076535A CN 101076535 A CN101076535 A CN 101076535A CN A2005800423787 A CNA2005800423787 A CN A2005800423787A CN 200580042378 A CN200580042378 A CN 200580042378A CN 101076535 A CN101076535 A CN 101076535A
Authority
CN
China
Prior art keywords
general formula
deoxy
difluoro
dibenzoate
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2005800423787A
Other languages
English (en)
Chinese (zh)
Inventor
A·-R·博恩
P·马丁
D·斯皮尔沃格尔
M·韦拉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sicor Inc
Original Assignee
Sicor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sicor Inc filed Critical Sicor Inc
Publication of CN101076535A publication Critical patent/CN101076535A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/048Pyridine radicals
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNA2005800423787A 2004-12-08 2005-12-08 二氟核苷及其制备方法 Pending CN101076535A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63437604P 2004-12-08 2004-12-08
US60/634,376 2004-12-08

Publications (1)

Publication Number Publication Date
CN101076535A true CN101076535A (zh) 2007-11-21

Family

ID=36147231

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2005800423787A Pending CN101076535A (zh) 2004-12-08 2005-12-08 二氟核苷及其制备方法

Country Status (10)

Country Link
US (1) US20060173174A1 (https=)
EP (1) EP1819718A1 (https=)
JP (1) JP2007522151A (https=)
KR (1) KR20070073958A (https=)
CN (1) CN101076535A (https=)
CA (1) CA2586687A1 (https=)
IL (1) IL183702A0 (https=)
MX (1) MX2007006837A (https=)
TW (1) TW200634022A (https=)
WO (1) WO2006063105A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104130301A (zh) * 2014-08-13 2014-11-05 陈欣 一种盐酸吉西他滨中间体的制备方法

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2778B1 (en) 2007-10-16 2014-03-15 ايساي انك Certain Compounds, Compositions and Methods
US8609631B2 (en) 2009-04-06 2013-12-17 Eisai Inc. Compositions and methods for treating cancer
JP5687687B2 (ja) 2009-04-06 2015-03-18 大塚製薬株式会社 癌を治療するための(2’−デオキシ−リボフラノシル)−1,3,4,7−テトラヒドロ−(1,3)ジアゼピン−2−オン誘導体
UY32546A (es) 2009-04-06 2010-10-29 Eisai Inc Composiciones y metodos para tratar cancer
AU2010234562B2 (en) 2009-04-06 2016-05-12 Taiho Pharmaceutical Co., Ltd. Combination of cytidine-based antineoplastic drugs with cytidine deaminase inhibitor and use thereof in the treatment of cancer
WO2025235664A1 (en) * 2024-05-07 2025-11-13 Emory University Purine nucleotide and nucleoside therapeutic compositions and uses related thereto

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH541566A (de) * 1969-04-11 1973-09-15 Schering Ag Verfahren zur Herstellung von Nucleosiden
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
ATE92499T1 (de) * 1984-12-04 1993-08-15 Lilly Co Eli Tumorbehandlung bei saeugetieren.
US4965374A (en) * 1987-08-28 1990-10-23 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
US5401838A (en) * 1992-06-22 1995-03-28 Eli Lilly And Company Stereoselective fusion glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
US5606048A (en) * 1992-06-22 1997-02-25 Eli Lilly And Company Stereoselective glycosylation process for preparing 2'-Deoxy-2', 2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
US5371210A (en) * 1992-06-22 1994-12-06 Eli Lilly And Company Stereoselective fusion glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
JPH0673086A (ja) * 1992-06-22 1994-03-15 Eli Lilly & Co 立体選択的な陰イオングリコシル化法
US5594124A (en) * 1992-06-22 1997-01-14 Eli Lilly And Company Stereoselective glycosylation process for preparing 2'-Deoxy-2',2'-difluoropyrimidine nucleosides and 2'-deoxy-2'-fluoropyrimidine nucleosides and intermediates thereof
US6828346B2 (en) * 1999-10-25 2004-12-07 Supergen, Inc. Methods for administration of paclitaxel
US7265096B2 (en) * 2002-11-04 2007-09-04 Xenoport, Inc. Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
CN1228342C (zh) * 2003-04-08 2005-11-23 深圳市汉德森技术有限公司 以1,6-脱水-β-D-葡萄糖为原料制备2'-脱氧-2',2'-二氟-β-核胞苷或其药用盐的方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104130301A (zh) * 2014-08-13 2014-11-05 陈欣 一种盐酸吉西他滨中间体的制备方法

Also Published As

Publication number Publication date
IL183702A0 (en) 2007-09-20
US20060173174A1 (en) 2006-08-03
JP2007522151A (ja) 2007-08-09
WO2006063105A1 (en) 2006-06-15
KR20070073958A (ko) 2007-07-10
CA2586687A1 (en) 2006-06-15
EP1819718A1 (en) 2007-08-22
MX2007006837A (es) 2007-10-23
TW200634022A (en) 2006-10-01

Similar Documents

Publication Publication Date Title
RU2200738C2 (ru) Способ синтеза нуклеозидных аналогов
EP0717748B1 (fr) Composes 2' ou 3'-deoxy- et 2', 3'-dideoxy-beta-l-pentofuranonucleosides, procede de preparation et application therapeutique, notamment anti-virale
EP1585529A2 (en) Process for the production of 2'-branched nucleosides
CN1311630A (zh) 具有双环糖部分的新核苷类
CN100335492C (zh) 生产3’-核苷前体药物的方法
CN1440292A (zh) 吡啶并[2,3-d]嘧啶和嘧啶并[4,5-d]嘧啶核苷
PL188447B1 (pl) Sposób wytwarzania pochodnych beta-nukleozydu dioksolanowego
KR102351734B1 (ko) 2'-플루오로-6'-메틸렌-탄소환식 아데노신(fmca) 및 2'-플루오로-6'-메틸렌-탄소환식 구아노신(fmcg)의 합성
CN1086519A (zh) 立体有择阴离子糖基化方法
HU208149B (en) Process for producing deoxyfluoronucleoside derivatives
JP2024054157A (ja) 修飾ヌクレオシドホスホロアミダイト
CN101076535A (zh) 二氟核苷及其制备方法
JP2017057200A (ja) 抗dnaウィルス活性などの生理活性を有するヌクレオシド誘導体
TW202128704A (zh) 雙環亞磷醯胺之製造方法
CN1812995A (zh) 工业化规模的核苷合成
EP1550665A1 (en) A process for the production of purine nucleoside compounds
WO2000039144A1 (fr) Procede de preparation de derives fluores de nucleosides et de sucres
EP0999218A1 (en) Process for producing nucleoside derivatives
CN1646452A (zh) 制备亚磷酸酯化(phosphitylated)化合物的方法
JP4174895B2 (ja) ヌクレオシド誘導体とその製法
JP4126823B2 (ja) ヌクレオシド誘導体及びその製造方法
WO2022256490A2 (en) Improved synthesis of phosphoramidates for the treatment of hepatitis b virus
EP4688781A1 (en) Methods and reagents for synthesizing haloaldehydes, and uses thereof
Pei et al. Synthesis of 3′-C-hydroxymethyl-substituted pyrimidine and purine nucleosides as potential anti-hepatitis C virus (HCV) agents
JP2006022009A (ja) 3−フルオロ−2,3−ジデオキシ−β−D−リボフラノシル型ヌクレオシド誘導体の製造方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20071121